In 2025, the European Medicines Agency concluded that NAION should be listed as a very rare side effect of semaglutide medications, including Ozempic, Wegovy, and Rybelsus, after reviewing clinical studies, adverse event reports, and post-market safety data
For qualified research professionals investigating advanced metabolic models, retatrutides triple-pathway activity makes it a structurally distinct compound from tirzepatide
If nausea from tirzepatide makes this challenging, electrolyte solutions and clear broths count toward your fluid goals
Such disturbances have been described in ASD brain tissue and support the relevance of methyl-donor pathways in ASD biology [32,33,34]
Gastrointestinal adverse events affect patients taking GLP-1 receptor agonists
nAMD is an eye condition where abnormal blood vessels grow in the back of your eye and blur the center of your vision